Skip to main content
BrainCited

Ginkgo biloba Cerebrovascular Health

B

Research suggests Ginkgo may help enhance cerebral blood flow through vasodilation. More consistent benefits are observed for vascular-related cognitive symptoms than for general cognitive decline.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dginkgo\u002Dbiloba\u0026condition\u003Dcerebrovascular\u002Dhealth'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

Research suggests Ginkgo may help enhance cerebral blood flow through vasodilation. More consistent benefits are observed for vascular-related cognitive symptoms than for general cognitive decline.

Key Study Findings

Review
[Treatment of mild cognitive impairment: value of citicoline].
Dose: None vs: None Outcome: cognitive function improvement in mild cognitive impairment 効果: None None

対象集団: elderly patients with mild cognitive impairment or chronic brain diseases

Review
Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines.
Dose: None vs: None Outcome: ASD symptom management 効果: None None

対象集団: Children with autism spectrum disorder

Other
Inhibition of mitochondrial oxidative stress and apoptosis in the protection of Ginkgo biloba extract 50 …
Dose: None vs: BCAS model mice without GBE50 Outcome: Cognitive impairment and white matter lesions 効果: None None

対象集団: BCAS cerebral small vessel disease mouse model

Meta-Analysis n=22347
Therapeutic strategies in vascular cognitive impairment: A systematic review and meta-analysis.
Dose: None vs: Various controls Outcome: Cognition and functional outcomes in VCI 効果: Ginkgo biloba: Cohen's d 0.83 [0.00-1.67] cognitio None

対象集団: Patients with vascular cognitive impairment (173 trials)

Other 10 weeks
Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of …
Dose: None vs: Untreated APP/PS1 mice Outcome: Cognitive performance in behavioral tests 効果: None None

対象集団: APP/PS1 transgenic Alzheimer's disease mouse model

In Vitro
Ginkgo biloba extract mediates HT22 cell proliferation and migration after oxygen-glucose deprivation/reoxygenation via regulating RhoA-ROCK2 …
Dose: None vs: OGD/R model vs control in HT22 cells Outcome: Cell proliferation and migration via RhoA-ROCK2 効果: None None

対象集団: HT22 mouse hippocampal neurons under OGD/R

Key Statistics

12

研究数

2000

参加者数

Positive

B

グレード

Referenced Papers

Revista de neurologia None 3 件の引用
Acta pharmaceutica Sinica. … 2024 33 件の引用
The Senior care … 2021 2 件の引用
Biomedicine & pharmacotherapy … 2020 427 件の引用
The Practitioner 2010
Prescrire international 2007 2 件の引用
Annals of clinical … 2003 47 件の引用
American family physician 2003
The Medical clinics … 2002 59 件の引用
Archives of physical … 2000 408 件の引用
Current opinion in … 1998 30 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones

上限量: 600 mg/day (doses above show no additional benefit)

研究で検討された用量

用量 期間 効果 N
None -- Positive --
None -- Positive --
None -- Positive --
None -- Positive 22347
None 10 weeks Positive --
None -- Positive --
None -- Positive --
None -- Positive --

推奨摂取タイミング: With meals; may require 4-6 weeks for full effects

Safety & Side Effects

報告されている副作用

  • Headache
  • Gastrointestinal upset
  • Dizziness
  • Allergic skin reactions (rare)
  • Increased bleeding risk

既知の相互作用

  • Anticoagulants and antiplatelet drugs (increased bleeding risk)
  • Anticonvulsants (may reduce seizure threshold)
  • SSRIs (serotonin syndrome risk, rare)
  • CYP3A4 substrates (may affect drug metabolism)

耐容上限摂取量: 600 mg/day (doses above show no additional benefit)

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Ginkgo biloba help with Cerebrovascular Health?
Based on 12 studies with 2,000 participants, there is moderate evidence from clinical studies that Ginkgo biloba may support Cerebrovascular Health management. Our evidence grade is B (Good Evidence).
How much Ginkgo biloba should I take for Cerebrovascular Health?
Studies have used various dosages. A commonly studied range is 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ginkgo biloba?
Reported side effects may include Headache, Gastrointestinal upset, Dizziness, Allergic skin reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ginkgo biloba and Cerebrovascular Health?
We rate the evidence as Grade B (Good Evidence). This rating is based on 12 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

に関する他の成分: Cerebrovascular Health

Ginkgo biloba 他の症状・状態について

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。